Palvella Therapeutics, Inc. (PVLA) Insider Ownership

Over the 90-day window ending January 10, 2026, Palvella Therapeutics's three dominant insider ownership positions are held by Director George M Jenkins (196.69K shares), Other Partners L P/Il Bvf (38.96K shares), TenPercentOwner Capital Management, Llc Adar1 (15.07K shares).

• Palvella Therapeutics's (PVLA) total shares are held approximately 39.39% by institutional investors, 1.16% by company insiders, and 59.45% by other and public investors.
• Current insider holdings at Palvella Therapeutics account for 1.16% of total shares outstanding as of January 10, 2026, totaling roughly 251.10K shares from the company's 21.65Mn share base.
• Over the past 90 days ending January 10, 2026, insider ownership at Palvella Therapeutics decreased by 15.47%, with aggregate insider holdings declining from 297.04K to 251.10K shares.
• As of January 10, 2026, Chief Operating Officer Kathleen Goin recorded the highest insider purchase activity at Palvella Therapeutics, accumulating 8.60K shares during the past 90 days.
• As of January 10, 2026, Chief Operating Officer Kathleen Goin executed the most significant insider divestiture at Palvella Therapeutics, disposing of 8.60K shares over the last 90-day period.